Cargando…
Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study
BACKGROUND: The incidence of lung cancer is rising in developing countries like India. Due to unaffordability among the low socioeconomic status (SES) patients, there is a significant delay in seeking appropriate medical treatment due to which a high proportion of patients present in an advanced/met...
Autores principales: | Kamath, Mangesh P, Lakshmaiah, KC, Babu, K Govind, Loknatha, D, Jacob, Linu A, Babu, Suresh MC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797433/ https://www.ncbi.nlm.nih.gov/pubmed/27051102 http://dx.doi.org/10.4103/0970-2113.177448 |
Ejemplares similares
-
Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience
por: Babu Kanakasetty, Govind, et al.
Publicado: (2016) -
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
por: Babu, Govind, et al.
Publicado: (2016) -
Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India
por: Rudresha, A. H., et al.
Publicado: (2017) -
Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
por: Babu, K. Govind, et al.
Publicado: (2019) -
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
por: Babu, K. Govind, et al.
Publicado: (2018)